Neuronetics, Inc. (STIM)
After hours:
| Previous close | 2.6100 |
| Open | 2.5800 |
| Bid | 2.4900 x 200 |
| Ask | 2.6200 x 100 |
| Day's range | 2.5110 - 2.6300 |
| 52-week range | 1.0300 - 5.0700 |
| Volume | |
| Avg. volume | 180,311 |
| Market cap | 75.894M |
| Beta (5Y monthly) | 2.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and olderMALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that Humana has become the first commercial payer to update its policy in response to the Company’s recent clearance from the U.S. Food and Dru
- GlobeNewswire
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
MALVERN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the first quarter of 2024. First Quarter 2024 Highlights First quarter 2024 revenue of $17.4 million, a 12% increase as compared to the
- GlobeNewswire
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 55,650 shares of the Company’s common stock (RSUs) to thirteen new non-executive employees. In accordance with NASDAQ Listing Rule
